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Abstract 
Caffeine inhibits 45Ca2+ sequestration by subplasmalemmal c cium stores ('alveolar sacs') of low thapsigargicin sensitivity which we 
have isolated from the ciliated protozoan, Paramecium tetraurelia. Inhibition depends on caffeine concentration, with an IC5o of 31.8 
raM. According to kinetic evaluation this is compatible with non-competitive inhibition of Ca 2+ uptake, rather than with superimposed 
45Ca2+ release during sequestration. It remains to be analysed whether this mechanism might be of possible relevance also for 
Ca2+-mediated activation in vivo in this or in any other secretory system. Such an effect could also operate indirectly, e.g., by 
CaZ+-release induction via sequestration i hibition. This is the first description of caffeine-mediated inhibition of Ca z+ uptake by calcium 
stores from a secretory system. Our data are compatible with some observations with sarcoplasmic reticutum from striated muscle fibers. 
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1. Introduction 
Caffeine (trimethylxanthine) is frequently used to in- 
duce exocytosis in a variety of cell types by mobilizing 
Ca 2÷ from intracellular stores [1-3]. Caffeine activated 
stores are frequently, though not always sensitive also to 
ryanodine or vice versa [3-5], but almost always they are 
insensitive to inositol 1,4,5-trisphosphate (InsP 3) [1,3]. The 
activation mechanism of caffeine is known to mimic 
CaZ+-induced Ca 2÷ release, CICR. This mechanism nor- 
mally involves a precedent increase of free intracellular 
Ca 2+ concentration, [Ca2÷]i, by mobilization from other 
sources [3]. Similarly caffeine is known to activate Ca 2÷ 
release from skeletal muscle SR [2,6] where it operates via 
the ryanodine receptor coupled to the voltage sensor in the 
cell membrane [7]. While a [Ca2+]i increase does not 
precede activation of SR in skeletal muscle in vivo [6], 
CICR or caffeine can trigger Ca 2+ release from isolated 
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SR in vitro [6]. In secretory cells, CICR or caffeine can 
trigger exocytosis, even when a voltage sensor-coupled 
ryanodine receptor does not occur. 
Altogether the mechanism of caffeine-induced Ca 2+ 
release, therefore, is not well understood, particularly in 
secretory cells. Also quite remarkable are the high concen- 
trations of caffeine required, up to 50 mM or even more, to 
achieve full activation of Ca 2÷ release and of secretion [8]. 
Intriguingly the Ca 2÷ release mechanism may depend on 
the concentration of Ca 2÷ and caffeine may exert different 
effects depending on the concentration applied [9]. Beyond 
this, caffeine is known to exert some other, widely differ- 
ent effects unrelated to Ca 2+ release (see Section 4). 
We have isolated 'alveolar sacs', the vast subplas- 
malemmal Ca 2+ stores from Paramecium cells [10,11] for 
functional characterization [12]. We have evidence that 
alveolar sacs provide Ca 2÷ for exocytosis of trichocysts in 
Paramecium [11-13]. We have also previously found that 
Ca 2÷ release cannot be induced by any of the established 
second messengers, including InsP 3 and cADPR [12]. 
Alveolar sacs possess a non-calmodulin stimulated Ca 2+- 
pump [10]. Inhibitors of SR-ER-type Ca2+-ATPases 
(SERCA) of intracellular calcium stores [14] cause reduced 
uptake of 45Ca2+ by isolated alveolar sacs in vitro and 
they trigger some trichocyst exocytosis in vivo, as does 
caffeine [12]. We now show that 45Ca2+ uptake is inhib- 
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ited in vitro not only by the SERCA inhibitor thapsigar- 
gicin (the less hydrophilic analogue of thapsigargin used in 
this study), though at relatively high concentrations, but 
also by caffeine - an aspect not previously recognized 
with any secretory system. This may be of possible impor- 
tance also for other secretory cells. 
2. Materials and methods 
We have isolated alveolar sac fractions from P. tetrau- 
relia wild-type (7S) cells according to Stelly et al. [10], in 
presence of protease inhibitors, as modified by L~nge et al. 
[12]. (See this reference also for detailed indications on 
methods, including protein and [Ca 2÷ ] determinations, and 
for sources of chemicals.) All chemicals were of the 
highest purity available. Thapsigargicin was from Cal- 
biochem (San Diego, CA), caffeine from Sigma (De- 
isenhofen, Germany). 45CAC12 (Amersham Buchler, 
Braunschweig, Germany) was used as an aqueous olution 
(38.9 MBq//zmol). 
Alveolar sac fractions were usually analysed in 20 mM 
Tris/maleate buffer pH 7.2, 250 mM sucrose, 5 mM 
MgCI 2, 5 U creatine phosphokinase (EC 2.7.3.2), 5 mM 
phosphocreatine and 1 mM Na2ATP. After 10 min prein- 
cubation at 27°C we added 20 /xM 45CAC12 (2.105 
Bq//zmol) to start 45Ca2+ uptake measurements over 10 
min. [Ca 2+ ] was kept at 20 /zM by control with a Ca 2+- 
selective lectrode [12]. In some experiments (Fig. 1) the 
sequence of adding ATP and Ca 2+ was reversed and 
occasionally ATP was omitted. ATP concentrations were 
eventually modified in experiments for Michaelis-Menten 
kinetics. Usually experiments were carded out with freshly 
isolated fractions ( ~ 100/zg of protein in an assay volume 
of 500/zl). An exception were experiments on 'ageing' of 
these fractions. 45Ca2+ retained in isolated fractions was 
determined, after washing with an excess of ice-cold wash- 
ing solution (20 mM Tris/maleate pH 7.2, 250 mM 
sucrose, 40 mM NaCI) on Whatman GF/C  glass microfi- 
bre filters, in a liquid scintillation counter. With some 
aliquots 45Ca2+ sequestration was ascertained by adding 
ionophore A23187. Alternatively adsorbed, i.e., non- 
sequestered 45Ca2+ was determined by experiments with- 
out ATP supply. The background values thus determined 
were below 10% of the actual total 45Ca2+ content of 
samples after washing. This background was subtracted. 
For determination of K M and Vma x values we used the 
Enzfitter computer program (Elsevier Biosoft). For analy- 
sis of statistical significance we performed a Student's 
t-test. 
3. Results 
We found that 45Ca2+ uptake by isolated alveolar sac 
fractions is reduced by ~ 60% within 24 h (0°C) after 
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Fig. 1. ATP-dependent 45Ca2+ sequestration shown in a typical experi- 
ment. Alveolar sac fractions were supplied with the ATP regenerating 
system 10 min after adding 45Ca2+ (upper curve, circles). Ionophore 
A23187 added after 60 min releases 45Ca2+ after sequestration. [ATP] = 
1.5 mM, free [Ca 2+ ] = 10 /xM. The lower curve (squares) was obtained 
in presence of 45Ca2+ but in absence of ATP. 
isolation (Table 1). Therefore, freshly isolated fractions 
were used throughout this work. We tried to rule out any 
influence of variable purity of fractions or of partial ageing 
on our kinetic analyses by running in parallel both, experi- 
ments and controls. 
To guarantee that isolated alveolar sacs sequester 45Ca2 + 
by an ATP-dependent mechanism, i.e., by a Ca 2 +-ATPase 
type pump, we recorded in Fig. 1 the absence of 45Ca2+ 
uptake in the absence of ATP (lower curve), the immediate 
beginning of 45Ca2+ uptake upon addition of ATP (upper 
Table 1 
• . 45  2 + Some characteristics of Ca uptake by alveolar sacs 
Ca 2 + 
K M 5.8 /xM 
Vma x 0.33 nmol /min/mg protein 
ATP 
K M 13.2 /zM 
Vma x 0.15 nmol /min/mg protein 
Caffeine 
ICs0 31.8 rnM 
'Ageing' 
Residual activity after 24 h (0°C) 40.5% 
S. Liinge et al. / Biochimica et Biophysica Acta 1278 (1996) 191-196 193 
curve) and 45Ca2+ release by ionophore A23187. In this 
experiment fractions were preincubated with 45Ca2+ be- 
fore activating the ATP regenerating system, opposite to 
experiments described below (see also Section 2). Never- 
theless, the time course of 45Ca2+ sequestration was quite 
similar when Fig. 1 is compared, e.g., with Figs. 2 and 3 
(10 min ATP preincubation ~ 45Ca2+ supply). 
From Lineweaver-Burk diagrams we calculated for 
Ca 2+ a K M = 5.8 /zM and a Wma x = 0.33 nmol /min /mg 
protein (data not shown). [Ca 2÷ ] was kept constant at 20 
/zM (see Section 2). Figs. 2 and 3 are typical experiments 
documenting increasing inhibition of 45Ca2+ uptake by 
increasing concentrations of either thapsigargicin or caf- 
feine. Subsequent release by the Ca2÷-ionophore A23187 
makes 45Ca2÷ leakage during uptake an unlikely explana- 
tion. Fig. 4 represents he dependency of 45Ca2+ uptake on 
ATP concentrations. Kinetic values for ATP dependency, 
as derived from Lineweaver-Burk plots, are K M = 13.2 
/zM and Vma x = 0. t5 nmol /min /mg protein for controls 
without caffeine (Fig. 4). According to Figs. 3 and 4, 
45Ca2+ sequestration is increasingly reduced by 10 mM 
and by 20 mM caffeine. In Fig. 4 values of Vma x are 
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Fig. 2. Typical experiment showing inhibition of 45Ca2+ uptake by 
thapsigargicin (TG). [ATP]= 1.5 mM, free [Ca 2+ ]= 10 /xM. Alveolar 
sacs were preincubated for 10 min with the ATP regenerating system 
before adding 45Ca2+. Data are normalized to100% for maximal seques- 
tration; for absolute values, ee Fig. 4. Sequestered 45Ca2+ is released by 
the Ca2+-ionophore A23187. 
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Fig. 3. Typical experiment showing inhibition of 45Ca2+ uptake by 
caffeine. [ATP]= 1.5 mM, free [Ca 2+ ]= 10 /xM. Alveolar sacs were 
preincubated for10 min with the ATP regenerating system before adding 
45Ca2+. Data are normalized to 100% for maximal sequestration; for 
absolute values, see Fig. 4. Sequestered ~5Ca2+ is released by the 
Ca 2 +-ionophore A23187. 
reduced from 0.15 nmol /min /mg protein (controls) to 
0.11 (10 mM caffeine) and 0.10 nmol /min /mg protein 
(20 mM caffeine). Statistical analysis of Fig. 4 revealed 
that these values are significantly different from controls 
on a level of P < 0.05. K M values for ATP derived from 
Lineweaver-Burk diagrams are 13.2 /xM for samples with- 
out caffeine, 13.0 with 10 mM caffeine and 12.1 /zM for 
20 mM caffeine. Statistical analysis showed these values 
of K M not to be significantly different (P  > 0.5). This 
formally indicates non-competitive inhibition of Ca 2 ÷ up- 
take. Essential data are summarized in Table 1. 
We also varied caffeine concentrations in presence of 
two widely different ATP concentrations, 0.1 and 1.5 mM 
(Fig. 5). With both ATP concentrations tested, 45Ca2÷ 
uptake without caffeine was normalized to 100% in Fig. 5. 
Absolute values for Ca 2÷ sequestered were 0.13 and 0.80 
nMol Ca2÷/min/mg protein, using 0.1 and 1.5 mM ATP, 
respectively. The curves in Fig. 5 decline by identical 
coefficients (without any statistically significant differ- 
ence) as caffeine concentrations are increased. This again 
supports non-competitive inhibition of 45Ca2+ uptake by 
caffeine. It also makes it unlikely that the effect of caf- 
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feine, in our case, would be due to latent 45Ca2+ release 
(diffusion) from the store during uptake since release 
would depend on the filling state, i.e., on ATP-concentra- 
tion dependent pump activation. This conclusion is sup- 
ported by the following data. In the experiments presented 
in Fig. 5 45Ca2+ uptake occurred for 10 min in presence of 
caffeine. The amount of 45Ca2+ sequestration achieved in 
Fig. 5 is about 5-times less than the amount we could 
release in previous work [12] by adding caffeine only after 
45Ca2+ sequestration was completed (also within 10 min 
and also using 1.5 mM ATP). For all these reasons we 
conclude that, with isolated alveolar sacs, caffeine causes 
inhibition of 45Ca2+ uptake, probably in a non-competitive 
mode, rather than any substantial release of 45Ca2+. Never- 
theless, in situ, the releasing effect may prevail (see Sec- 
tion 4). 
We determined the concentration of caffeine required 
for 50% inhibition of 45Ca2+ uptake as ICs0 = 31.8 mM 
(Table 1). For TG, an ICs0 ~ 5 /xM and an ICl00 ~ 20/~M 
can be extrapolated from experiments of the type shown in 
Fig. 2. Extrapolation to full inhibition would result in 
values well beyond 50 /xM, as required for full activation 
of calcium stores in some other secretory systems [8]. 
4. D iscuss ion  
We interpret the data obtained with our in vitro system, 
the subplasmalemmal calcium stores isolated from 
Paramecium cells, as inhibition of Ca 2" uptake by caf- 
feine. Our data are formally compatible with non-competi- 
tive inhibition of Ca 2+ uptake. It has previously been 
shown that a SERCA-type Ca2+-pump occurs in alveolar 
sacs [10,12]. We also have shown that, in vitro, the release 
of sequestered 45Ca2+ achieved with caffeine is as slow as 
with SERCA inhibitors, whereas in vivo caffeine provokes 
rapid trichocyst exocytosis [12] and rapid [Ca 2+ ]i increase 
(not shown). It remains to be seen whether Ca2"-pump 
inhibition by caffeine plays a role in vivo or whether in 
this case a genuine Ca 2-- releasing effect may prevail. 
Interestingly not only caffeine (see Section 1) but also 
SERCA inhibitors can cause a simultaneous induction of a 
[ Ca2" ]i increase and of secretory activity with a variety of 
electrically excitable or non-excitable c lls [ 15-17]. 
Besides activation of CICR in some systems (see Sec- 
tion 1), several other unrelated effects have been observed 
with caffeine [2,3,18]. Among them are the inhibition of 
voltage-gated Ca channels and of K channels in pancreatic 
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Fig. 4. [ATP] dependent 45Ca2+ uptake (10 min, 27°C) by alveolar sacs and its inhibition by caffeine. Each data point is the mean of four independent 
experiments. (Ordinate: × 10 -I (inset × 101), abscissa: X 10 -~ (inset × 102)). Values for K u and Vm, x were determined by the Enzfitter computer 
program. Circles=no caffeine (KM = 13.2 /~M, Vma x =0.15 nmol /min/mg protein); squares= 10 mM caffeine (K M = 13.0 /~M, Vma X =0.11 
nmol /min/mg protein); triangles = 20 mM caffeine (K M = 12.1, Vma x= 0.10 nmol /min/mg protein). Whereas K M values obtained with the two 
caffeine concentrations tested are not significantly different from controls (P > 0.5), values calculated for Vma ~ are significantly different on a P < 0.05 
level. 
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Fig. 5. Inhibition of 45Ca2+ uptake by caffeine does not depend on ATP 
concentration. For one series we used 1.5 mM ATP (standard conditions), 
for another series only 0.1 mM ATP. Values without caffeine are 
normalized to 100%; for absolute values, see text. Caffeine inhibited 
45Ca2+ sequestration equally under both conditions. An IC50 = 31.8 mM 
was calculated. 
tions more clearly showed the inhibition of Ca 2 ÷ uptake or 
of Ca2+-ATPase activity, respectively [30,31]. 
The following aspects have to be kept in mind with 
secretory systems. In widely different cells SERCA-type 
pumps may be sensitive to caffeine or to established 
inhibitors to a different extent. As with our system, caf- 
feine has to be applied at relatively high concentrations to
achieve full activation of Ca 2÷ release even with some 
mammalian secretory cells [8]. Some populations of mast 
cells from rat also require 20 /~M thapsigargin to trigger 
maximal histamine release [15] and even higher concentra- 
tions are required to reduce the peak amplitude of 
caffeine-induced contracture in skinned fibres from frog 
skeletal muscle [32]. Finally, latent thapsigargin i cubation 
causes expression of a SERCA-type pump of low thapsi- 
gargin sensitivity in some mammalian cells [33,34], with 
an IC50 ~ 4 /xM [34]. Similarly we found alveolar sacs to 
be little sensitive to TG (ICs0 ~ 5 /zM), and possibly this 
SERCA-type may be selectively inhibited by caffeine. It 
also has to be kept in mind that effects achieved in vitro 
may not strictly reflect the situation in vivo and our failure 
to induce CICR in vitro [12] might be due to loss of 
regulatory components in these studies. Nevertheless, se- 
cretory systems may be activated by a small amount of 
[Ca2+] i increase which can be caused by Ca2+-pump 
inhibition and which secondarily may induce an extensive 
response via CICR. Clearly more detailed analyses are 
required to settle these aspects in our as well as in other 
secretory systems. 
5. Conclusions 
fl-cells [19], activation of non-selective cation channels 
(carrying also Ca z ÷ ) in gastric smooth muscle cells [20], as 
well as inhibition of phosphodiesterase activity in some 
cells [2,18]. Furthermore, in pancreatic acinar cells caffeine 
activates (at low concentration) or blocks (at higher con- 
centrations) agonist induced [Ca2+]i oscillations [21], as it 
does in oocytes [22,23] and in hepatocytes [24]. In the 
latter case suppression of InsP3-mediated Ca 2 + release by 
caffeine has been proposed [23,25]. Thus, caffeine may not 
simply be regarded as a CICR activator, but one also has 
to consider some 'unorthodox' effects. Among them the 
Ca 2÷ transport inhibition described here is novel for secre- 
tory cells and may be relevant also for other systems. 
So far to our knowledge the effect of caffeine on Ca 2 ÷ 
sequestration by isolated calcium stores has been analysed 
only with SR, with the following intriguing results. Al- 
though caffeine reduced Ca 2+ uptake [26], this effect was 
believed to be due to superimposed Ca 2+ release, rather 
than to inhibition of the Ca 2+ pump [27,28]. A more 
scrutinized analysis revealed either activation or inhibition 
of Ca 2÷ uptake by caffeine-related drugs, depending on 
conditions used [29]. More recent analyses with SR frac- 
It cannot be taken for granted that caffeine activates 
secretory systems only by the mechanisms commonly as- 
sumed, i.e., by direct activation of Ca 2+ release channels 
in subcellular stores. Even small inhibition of Ca 2+ se- 
questration could be amplified by CICR and, thus, has to 
be envisaged as an additional or alternative mechanism of 
the Ca2+-dependent activation phenomena observed with 
caffeine in secretory systems. 
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